Free Trial

Conduit Pharmaceuticals (CDT) SEC Filings & 10K Form

Conduit Pharmaceuticals logo
$0.07 0.00 (-6.25%)
Closing price 04:00 PM Eastern
Extended Trading
$0.07 +0.00 (+3.56%)
As of 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Conduit Pharmaceuticals SEC Filings

DateFilerForm TypeView
01/15/2025
3:30 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
12/20/2024
4:05 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2024
4:06 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:06 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:06 PM
Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:06 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
4:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
4:01 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
12/09/2024
7:30 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEF 14A
12/08/2024
11:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
12/09/2024
5:11 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
11/26/2024
4:21 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form PRE 14A
11/25/2024
4:10 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/25/2024
3:53 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:20 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:22 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q/A
11/14/2024
4:24 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q/A
11/14/2024
4:27 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
5:01 AM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
St George Street Capital (Filed by)
Form SC 13G/A
11/04/2024
4:20 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
11/04/2024
4:21 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
11/03/2024
11:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
11/01/2024
4:10 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEFA14A
11/01/2024
3:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
4:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEF 14A
10/28/2024
4:16 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEFA14A
10/28/2024
4:17 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form ARS
10/24/2024
5:12 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/18/2024
3:15 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SC 13G/A
10/16/2024
4:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form PRE 14A
10/15/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
5:01 AM
ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Form SC 13G
10/07/2024
6:36 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SC 13G/A
10/07/2024
6:38 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:02 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:59 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Corvus Capital Ltd. (Filed by)
Form SC 13D/A
09/19/2024
4:01 PM
Algo Holdings, Inc. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:41 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
09/16/2024
11:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
09/06/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Free Stock Ticker Inside: This Indicator Caught Nvidia’s Rallies (Ad)

I’m not one to make super bold statements… But today, I’m making an exception. Because I’m 100% convinced this is the best indicator I’ve used for trading Nvidia… Don’t believe me? Just take a look at the last two rallies: This powerful indicator caught both moves almost perfectly.

Don’t miss out—this could be the next big move.
09/04/2024
3:44 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/19/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
08/16/2024
3:59 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:29 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:30 AM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
4:53 PM
Bligh James (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:56 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
05/14/2024
3:05 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
11:15 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
04/24/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Intelmed LLC (Reporting)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
4:00 PM
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Tapolczay David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
4:27 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
4:29 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
3:30 PM
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form NT 10-K
02/12/2024
11:51 AM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SC 13G/A
02/08/2024
12:15 PM
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CDT) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners